Halley E Gilbert Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Halley E Gilbert is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 22,123 shares of ARQT, which is worth approximately $553,075. The most recent transaction as insider was on Nov 20, 2025, when has been sold 16,532 shares (Common Stock) at a price of $27.55 per share, resulting in proceeds of $455,456. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.1K

16.31% 3M change

17.51% 12M change

Total Value Held $553,075

Halley E Gilbert Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2025	SELL Open market or private sale	$455,456 $27.55 p/Share	16,532 Reduced 42.77%	22,123 Common Stock
Nov 20 2025	BUY Exercise of conversion of derivative security	$91,772 $7.51 p/Share	12,220 Added 24.02%	38,655 Common Stock
Jun 12 2025	BUY Grant, award, or other acquisition	-	7,609 Added 22.35%	26,435 Common Stock
Jun 14 2024	BUY Grant, award, or other acquisition	-	10,139 Added 35.0%	18,826 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	4,375 Added 33.49%	8,687 Common Stock
Jun 01 2022	BUY Grant, award, or other acquisition	-	4,312 Added 50.0%	4,312 Common Stock

Also insider at

PCVX

Vaxcyte, Inc. Healthcare

Director

CTMX

CytomX Therapeutics, Inc. Healthcare

NEO

NEOGENOMICS INC Healthcare

Chief Legal Officer

HEG

Halley E Gilbert

Director

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Value

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT

Account